Mandate

Vinge advises Active Biotech on rights offering

November 24, 2014

Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights offering of SEK 225 million. Vinge advises Active Biotech.

The Vinge team primarily consists of Erik Sjöman (partner, capital markets & public M&A) and associates Christian Lindhé, Ludvig Frithiof and Madelene Eriksson.

Related

Vinge advises Vimian in connection with new RCF and issuance of senior unsecured bonds

Vinge advises Vimian Group AB (publ) (“Vimian”) in connection with a new EUR 330 million multicurrency revolving facility agreement and its issuance of senior unsecured bonds in an amount of EUR 150 million (within a framework of EUR 250 million)
May 28, 2025

Vinge represents Alrik Technologies in connection with their latest funding round

Vinge has represented Alrik Technologies in connection with their latest funding round led by People Ventures, with Pi Labs doubling down on their investment.
May 27, 2025

Vinge advises Trinax in connection with the acquisition of Struqtur

Trinax, a Helix Kapital portfolio company, has acquired Struqtur, a Swedish company offering a comprehensive cloud-based software solution for time reporting, project management and work orders.
May 26, 2025